Yayın:
An Overview on Lambda, Epsilon, Kappa, Iota and Zeta Variants of Covid-19 and its Probability to Merge with Delta & Delta Plus, why it is a Concern

dc.date.accessioned2026-01-05T23:03:34Z
dc.date.issued2021-11-20
dc.description.abstractCOVID-19 is caused by the virus SARS-CoV-2 that belongs to the Corona groups. The subgroups of the coronavirus families are α, β, γ, and δ coronavirus. On June 15, 2021, the string λ of SARS-CoV-2 was evaluated as a variant of interest via the World Health Organization. This string has a high prevalence in some parts of South American countries, but it occurred only occasionally in Brazil. This study confirms that mutations in the λ -spike protein can be destroyed the neutralizing antibodies and increase infectivity. Coronaviruses such as SARS-CoV-2 have an evolutionary superpower called “recombination” which permits the mixing of their genomes into novel combinations. Unlike regular mutation, which precedes slowly one change at a time, recombination can produce whole changes in a coronavirus genome. Although right now, δ-variant is a concern, a mixing of λ with other variants such as δ-variant is much more of a concern compared to alone variants. There is another item: the recombination can arise within the sample after it was taken from the infected person, not while it was inside their body.
dc.description.urihttps://doi.org/10.33263/briac125.68956914
dc.description.urihttps://dx.doi.org/10.33263/briac125.68956914
dc.identifier.doi10.33263/briac125.68956914
dc.identifier.eissn2069-5837
dc.identifier.endpage6914
dc.identifier.openairedoi_dedup___::615bb5a4aeddfaf86f1923cc364b0cdc
dc.identifier.scopus2-s2.0-85119368420
dc.identifier.startpage6895
dc.identifier.urihttps://hdl.handle.net/20.500.12597/43540
dc.identifier.volume12
dc.identifier.wos000721362000023
dc.language.isoeng
dc.publisherAMG Transcend Association
dc.relation.ispartofBiointerface Research in Applied Chemistry
dc.rightsOPEN
dc.subject.sdg3. Good health
dc.titleAn Overview on Lambda, Epsilon, Kappa, Iota and Zeta Variants of Covid-19 and its Probability to Merge with Delta & Delta Plus, why it is a Concern
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":null,"openAccessColor":"gold","publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"FOS","value":"0106 biological sciences"},"provenance":null},{"subject":{"scheme":"FOS","value":"0404 agricultural biotechnology"},"provenance":null},{"subject":{"scheme":"FOS","value":"04 agricultural and veterinary sciences"},"provenance":null},{"subject":{"scheme":"FOS","value":"01 natural sciences"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null}],"mainTitle":"An Overview on Lambda, Epsilon, Kappa, Iota and Zeta Variants of Covid-19 and its Probability to Merge with Delta &amp; Delta Plus, why it is a Concern","subTitle":null,"descriptions":["<jats:p>COVID-19 is caused by the virus SARS-CoV-2 that belongs to the Corona groups. The subgroups of the coronavirus families are α, β, γ, and δ coronavirus. On June 15, 2021, the string λ of SARS-CoV-2 was evaluated as a variant of interest via the World Health Organization. This string has a high prevalence in some parts of South American countries, but it occurred only occasionally in Brazil. This study confirms that mutations in the λ -spike protein can be destroyed the neutralizing antibodies and increase infectivity. Coronaviruses such as SARS-CoV-2 have an evolutionary superpower called “recombination” which permits the mixing of their genomes into novel combinations. Unlike regular mutation, which precedes slowly one change at a time, recombination can produce whole changes in a coronavirus genome. Although right now, δ-variant is a concern, a mixing of λ with other variants such as δ-variant is much more of a concern compared to alone variants. There is another item: the recombination can arise within the sample after it was taken from the infected person, not while it was inside their body.</jats:p>"],"publicationDate":"2021-11-20","publisher":"AMG Transcend Association","embargoEndDate":null,"sources":["Crossref"],"formats":null,"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_abf2","label":"OPEN","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Biointerface Research in Applied Chemistry","issnPrinted":null,"issnOnline":"2069-5837","issnLinking":null,"ep":"6914","iss":null,"sp":"6895","vol":"12","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::615bb5a4aeddfaf86f1923cc364b0cdc","originalIds":["10.33263/briac125.68956914","50|doiboost____|615bb5a4aeddfaf86f1923cc364b0cdc","3216654431"],"pids":[{"scheme":"doi","value":"10.33263/briac125.68956914"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":2,"influence":2.568488e-9,"popularity":3.140989e-9,"impulse":2,"citationClass":"C5","influenceClass":"C5","impulseClass":"C5","popularityClass":"C5"}},"instances":[{"pids":[{"scheme":"doi","value":"10.33263/briac125.68956914"}],"type":"Article","urls":["https://doi.org/10.33263/briac125.68956914"],"publicationDate":"2021-11-20","refereed":"peerReviewed"},{"pids":[{"scheme":"doi","value":"10.33263/briac125.68956914"}],"type":"Article","urls":["https://doi.org/10.33263/briac125.68956914"],"refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"mag_id","value":"3216654431"},{"scheme":"doi","value":"10.33263/briac125.68956914"}],"type":"Other literature type","urls":["https://dx.doi.org/10.33263/briac125.68956914"],"refereed":"nonPeerReviewed"}],"isGreen":false,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atWOS
local.indexed.atScopus

Dosyalar

Koleksiyonlar